MedTrace Logo

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

NCT03437109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 554

Last updated 2019-06-20

No results posted yet for this study

Summary

The purpose of the study is to get data of prevalence of testosterone deficiency in patient with T2DM in Russian Federation

Conditions

  • T2DM (Type 2 Diabetes Mellitus)
  • Hypogonadism

Interventions

DIAGNOSTIC_TEST

Laboratory tests

Testosterone HSBG Hb1Ac LH

Sponsors & Collaborators

  • Besins Healthcare

    lead INDUSTRY

Principal Investigators

  • Marina SHESTAKOVA, academitian · ENC

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-06
Primary Completion
2019-02-01
Completion
2019-02-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03437109 on ClinicalTrials.gov